Tag: Novartis Oncology
2020 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…
READ MORE
8th Annual Warner Advocacy Award: Call for Nominations
Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize …
READ MORE Call for Nominations: 7th Annual Warner Advocacy Award
Novartis Oncology and The NET Alliance have announced that nominations are open for the 7th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize the …
READ MORE
Call for Nominations: 6th Annual Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? Novartis Oncology and The NET Alliance are searching for an outstanding NET patient advocate to recognize and honor with the 6th Annual Warner Advocacy …
READ MORE
10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…
READ MORE
Call for Nominations: 2014 Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? The NET Alliance™ and Novartis Oncology have announced the 2014 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind the…
READ MORE
Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program
A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.
With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…
READ MORENew Jersey Carcinoid Cancer NETwork Conference Videos Now Available
Carcinoid and neuroendocrine tumor (NET) patients, physicians, caregivers, support group leaders and patient advocates gathered to learn more from nationally and internationally recognized carcinoid/NET specialists and local physician specialists…
READ MORE
10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…
READ MORE
Call for Nominations: 2013 Warner Advocacy Award
Novartis Oncology has announced the 2013 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind the Carcinoid Cancer Foundation for two decades and extraordinary advocate for carcinoid and neuroendocrine tumor patients.…
READ MORE